The Buzz Surrounding: CanaFarma Hemp Products Corp. (CSE: CNFA) | Financial Buzz

The Buzz Surrounding: CanaFarma Hemp Products Corp. (CSE: CNFA)

CanaFarma Hemp Products Corp. offers products that improve human well-being

According to the Company – Experts from diferent countries are sure that hemp oil is one of the best superfoods that should be in the diet of people leading a healthy lifestyle.

This product can be recommended for both adults and children from an early age. It is suitable for people who are supporters of vegetarianism, and women should pay special attention, since the product can be used to enhance lactation during breastfeeding, as a therapeutic and prophylactic against osteoporosis, which many women experience after menopause. During pregnancy, hemp seed oil is recommended as an aid in the fight against edema.

Our Behind the Buzz Show Featuring
CanaFarma Hemp Products Corp. 

Investor Recap

Vertical Integrated
Hemp Business

Vertical integrated business:

  • Cultivation
  • Processing
  • 3 Sales and distribution
  • Flexibility and quality control on each stage
  • Accumulates margins of the supply chain

YOOFORIC™ — Hemp Infused Oil

The Brand

YOOFORIC™ — flagship Product.
Hemp Oil Infused Chewing Gum

  • Patent pending technology maximizes cannabinoids absorption.
  • Potency per serving: 50 mg hemp oil hemp, 10 mg phytocannabinoids.
  • Full spectrum hemp oil.
  • No THC. Certified organic.
  • FDA registered facility.
    GMP certified manufacturing.
  • Legal in 50 states.

Full spectrum 100% pure hemp oil

  • All the cannabinoids found in the hemp plant
  • Omega 3 and Omega 6 fatty acids at a perfect 3:1 ratio 
  • Vitamins and nutrients
  • Certified organic
  • Legal in 50 states

YOOFORIC™ — Hemp Infused Oil

YOOFORIC Hemp Oil Infused Cream:

  • Hemp Oil Rich in Phytocannabinoids.
  • Premium Ingredients specifically designed to Target Inflammation, Chronic Joint and Muscle Soreness.
  • Relaxing Aromatic Botanical Fresh Mint Scent.
  • Manufactured in FDA. Registered, Audited and GMO Certified Facility..

The Products Help Improve People’s Health

Recent Developments

Press Releases:

May 14, 2020 - CanaFarma Hemp Products Corp. Announces Sales Data Analysis

CanaFarma Hemp Products Corp. (CSE:CNFA) (the “Company” or “CanaFarma”) is pleased to announce that it has conducted an analysis of its product sales from its first six months of sales activity (from June to November 2019).

Sales of CanaFarma’s first two products, YOOFORIC™ chewing gum and YOOFORIC™ tincture, commenced in June 2019. CanaFarma has completed this review of its first six months of revenues in order to assess its marketing direct response model. The following customer statistics relative to such period have been noted:

  1. The re-order rate of products by customers in its YOOFORIC™ brand was 68%.
  2. The daily order count was approximately 300 orders per day, which was in line with budget expectations.
  3. The cost to acquire customers or Cost Per Acquisition (“CPA”) was 10% lower than had been budgeted.
  4. The Company’s re-marketing efforts to customers achieved results which were 28% better than projections.
  5. 65% of customers also chose to try a second product under the YOOFORIC™ brand, demonstrating a high degree of confidence in our brand equity and credibility.

David Lonsdale, CEO of CanaFarma said, “We are gratified by the response that our customers have shown to our marketing efforts. These results provide us a great deal of confidence in our marketing approach as we look to scale up our marketing and sales efforts in the future.”

For full release:

May 12, 2020 - Canafarma Hemp Products Corp. Announces the Development of Its Acne Cream

 CanaFarma Hemp Products Corp. (CSE:CNFA) (the “Corporation” or “CanaFarma”) is pleased to announce that its research and development division has begun developing its newest hemp-oil infused product line for skincare. The first product in this new line is a hemp oil infused cream designed to help combat skin conditions related specifically to Acne.

Acne Vulgaris is a skin disease afflicting 79% to 95% of the adolescent population. In men and women older than 25 years, 40% to 54% have some degree of facial acne, and clinical facial acne persists into middle age in 12% of women and 3% of men(1). The psychological issues arising from Acne are serious and often damaging.

CanaFarma has been developing this formulation together with Carl Germano, CNS, CDN, who is an authority in the cannabinoid and nutritional industry. The cream is designed to provide relief support to sufferers from Acne utilizing the most advanced actives and botanicals. Mr. Germano is a NY board-certified clinical nutritionist and expert in cannabinoid product development, and Vice-President of Verdant Oasis, a leading grower, extractor and supplier of cannabinoid rich-hemp oil.

The product, which is expected be launched by the end of Q2’20, is formulated to utilize the full cannabinoidal spectrum found in hemp oil to target three common characteristics of Acne Vulgaris:

  • Oil Production. A 2014 study published in the Journal of Clinical Investigation(2) explored the effects of cannabinoids on the oily secretions (sebocytes), which are the cells that create sebum. The researchers found that cannabinoids prevented these cells from creating too much of the oily sebum, an oily, waxy substance designed to protect the skin. When these glands over-produce sebum, the sebum clogs pores, resulting in acne.
  • Inflammation. This same research also revealed that the active cannabinoids found in hemp oil contributed to an anti-inflammatory reaction in the cells. When acne occurs, pimples are red, inflamed and often painful.
  • Bacteria. A 2016 review of the Hemp plant published by Experimental Dermatology(3) highlighted its antibacterial and antifungal effects. Such effects could help reduce infections from dirt and other pollutants on the skin, which can further contribute to acne.

CanaFarma will be announcing the official delivery date of its product expected by end of Q2’20 and looks forward to introducing this new offering for people who are suffering from acne related problems.

David Lonsdale, CEO of CanaFarma said, “Medical Science is only just beginning to understand the benefits of Hemp Oil and the cannabinoids that it contains. CanaFarma is committed to delivering quality science-based products targeted towards specific benefits to the consumer. I am delighted to be announcing our Acne Cream and look forward to it being available to our customers.”

(1) Arch Dermatol. 2002;138(12):1584-1590. doi:10.1001/archderm.138.12.1584.
(2) Journal of Clinical Investigation Volume 124 Number 9 September 2014.
(3) Experimental Dermatology EXD-15-0557.R3 12th April 2016.

For full release:

May 8, 2020 - CanaFarma Hemp Products Corp. Announces U.S.$20 Million Offering

CanaFarma Hemp Products Corp. (CSE:CNFA) (the “Company” or “CanaFarma”) is pleased to announce a private placement of units (each, a “Unit”) at a price of Cdn$0.63 per Unit for aggregate gross proceeds of up to U.S.$20,000,000 (approximately Cdn$28,300,000) (the “Offering”). Each Unit shall consist of one (1) common share (a “Common Share”) and one common share purchase warrant (a “Warrant”), with each whole warrant entitling the holder to purchase one (1) Common Share at an exercise price of Cdn$0.78 per Common Share for a period of five (5) years from the date of the first closing under the Offering.

Closing of the Offering is expected to occur upon completion of formal documentation and receipt of all necessary regulatory approvals. In accordance with applicable securities laws, all of the Common Shares and Warrants issued under the Offering will be subject to a four (4) month plus one day hold period.

The net proceeds of the Offering will be used for the purposes of funding the potential acquisition of manufacturing and extraction facilities, increasing the acreage of our grow business, scaling our sales and marketing activities, completing complimentary or synergistic mergers or acquisitions (if, as and when determined by the board of directors), R&D and for general working capital and corporate purposes.

The securities offered hereby have not and will not be registered under the United States Securities Act of 1933 (the “1933 Act”) and may not be offered or sold in the United States or to U.S. persons (as defined in Regulation S under the 1933 Act) unless the securities have been registered under the 1933 Act, or are otherwise exempt from such registration.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

For full release:

May 5, 2020 - CanaFarma Hemp Products Corp. Enters into an Agreement with Proactive Investors

CanaFarma Hemp Products Corp. (CSE:CNFA) (the “Company” or “CanaFarma”) is pleased to announce that it has engaged Proactive Investors (“Proactive”) to provide investor relations services for the Company.

The Company agreed to pay Proactive £25,000 pounds sterling pursuant to the engagement, which has a twelve month term and expires in April 2021. Proactive will provide certain corporate branding, marketing and investor relations services to the Company.

Proactive has also initiated a research report on the Company and has advised the Company that it expects to publish its report on May 6, 2020.

For full release:

April 28, 2020 - CanaFarma Hemp Products Corp. Announces Frank Barone As Its Chief Operating Officer

CanaFarma Hemp Products Corp. (CSE: CNFA.CN) (the “Corporation” or “CanaFarma”) is pleased to announce that it has promoted Frank Barone to the position of Chief Operating Officer (COO), as the Corporation continues to build out its executive management team to support its future growth.

Over the past 18 years Mr. Barone has co-founded several consumer goods and services companies, including Barmensen Development, Next Gen Health Solutions and Associate Design LLC. Each company specialized in taking nutritional supplements and cosmetics to market using Direct-to-Consumer strategies via both off-line (e.g., TV, Radio, Print), and on-line (e.g., Affiliate Marketing, SEO, Social Media), prior to introducing such products into both electronic and brick and mortar retail. In each instance, Mr. Barone oversaw all aspects of the business, including financial and operational infrastructure, channel strategy, legal and business development.

Prior to 2002, Mr. Barone was the Chief Operations Officer for a financial technology holdings company which held two SEC-registered subsidiary broker-dealers.

Mr. Barone received his BS from St. John’s University and his Juris Doctorate degree from St. John’s University School of Law.

David Lonsdale, CEO of CanaFarma commented: “We are very pleased to be putting Frank in charge of the operations of CanaFarma. He is a talented and seasoned executive in whom we have a great deal of confidence. I am looking forward to working closely with Frank as we execute on the strategies that we have developed.”

For full release:

April 24, 2020 - CanaFarma Hemp Products Corp. Signs LOI To Acquire Manufacturing Facility

CanaFarma Hemp Products Corp. (CSE: CNFA) (the “Corporation” or “CanaFarma”) is pleased to announce that it has signed a Letter of Intent (“LOI”) with a privately held company to acquire a manufacturing facility for its hemp oil-based consumer products operations.

The potential acquisition would include a 25,000 square foot facility in  New Jersey, of which the private company currently uses a small part of the facility to manufacture certain pharmaceutical and nutraceutical products under “current Good Manufacturing Practices” (cGMP).  It is the Corporation’s intention to acquire and continue to produce these products under the cGMP designation, as well as to expand the use of the facility to manufacture Canafarma’s YOOFORIC brand hemp oil-based consumer products.

The LOI is non-binding and a due diligence period is currently underway which, if successful, will be followed by the negotiation of a definitive agreement for the acquisition of all of the assets of the private company.

David Lonsdale, CEO of CanaFarma said, “This has the potential to be another substantial step forward for CanaFarma, as we continue to execute on our overall strategic plan to build a completely vertically-integrated hemp-based company.  Having our own manufacturing facility would not only allow us to scale production in support of our growing sales and product line expansion, but also to bring new innovative products to market much faster under a more efficient and controllable cost structure.”

For full release:

April 20, 2020 - CanaFarma Hemp Products Corp. Announces Launch of Hemp Oil Infused Cream Under Yooforic Brand

CanaFarma Hemp Products Corp. (CSE: CNFA.CN) (formerly KYC Technology Inc.) (the “Corporation” or “CanaFarma”) is pleased to announce that it has launched a new hemp oil infused cream under its YOOFORIC brand.

YOOFORIC Hemp Oil Infused Cream for Joint & Muscle support contains premium ingredients that target inflammation, chronic joint and muscle soreness. Its light aromatic botanical blend is designed to help soothe tired muscles and joints on contact. The creamy gel-like texture is light and airy, and the cream absorbs at the dermis level without leaving a greasy residue.

YOOFORIC Hemp Oil Infused Cream also contains a powerful cooling menthol together with naturally occurring hemp-based phytocannabinoids. When applied directly to the area of discomfort, the formula absorbs quickly and these cannabinoids engage with endocannabinoid receptors in the skin to directly target the discomfort. YOOFORIC Hemp Oil Infused Cream causes no high or drowsiness, and like all of our innovative products, YOOFORIC Hemp Oil Infused Cream is manufactured in an FDA Registered, Audited and GMO Certified Facility.

David Lonsdale, CEO of CanaFarma commented: “We are very pleased to be launching a product that we believe will bring relief to many people suffering from joint and muscle soreness. This product is expected to be an excellent addition to our YOOFORIC line of products.”

For full release:

March 19, 2020 - CanaFarma Hemp Products Corp. Announces Lease of 100 Acre Farm

CanaFarma Hemp Products Corp. (CSE: CNFA)    (formerly KYC Technology Inc.) (the “Corporation” or “CanaFarma Hemp”) is pleased to announce that it has signed a lease for 100 acres of farmland in Cato, New York, almost doubling the size of the farm the Company had in 2019.

In 2019, CanaFarma Hemp worked a 55 acre farm in New York State and delivered 128,000 lbs. of Hemp Biomass, achieving a yield of over 2,300 lbs. per acre which is 50% better than the average farm yield, which the management of the Company believe to be in the range of 1,500 lbs. per acre. Furthermore, the CBD potency of the Biomass was over 14%, compared to the average potency which is believed to be approximately 10%.

David Lonsdale, CEO of CanaFarma commented: “We are obviously very pleased with the harvest we achieved in 2019 and we will be endeavoring to continue this level of performance in 2020”.

CanaFarma Hemp is also actively looking at further expanding its Farm acreage both in New York State and in neighboring States.

About CanaFarma Hemp Products Corp.

CanaFarma Hemp is a full-service company operating in the hemp industry offering a full range of hemp-related products and services. These products and services include growing top-quality hemp, providing hemp-processing services, and offering hemp-based products to consumers utilizing a direct-to-consumer marketing approach.

For full release:

March 16, 2020 - CanaFarma Hemp Products Corp. Announces Revised CSE Listing Date

CanaFarma Hemp Products Corp. (formerly KYC Technology Inc.) (CSE:CNFA) (the “Corporation” or “CanaFarma Hemp”) announces that its Common Shares will commence trading on the Canadian Securities Exchange (CSE) under the symbol “CNFA” at the opening of markets on Thursday, March 19th, 2020. This initial listing date has been pushed back from March 17, 2020 at the request of the Corporation in order to account for world events relating to the COVID-19 virus, which are expected to have caused extra delay in shareholders receiving their new shares of the Corporation.

About CanaFarma Hemp Products Corp.

CanaFarma Hemp is a full-service company operating in the hemp industry offering a full range of hemp-related products and services. These products and services include growing top-quality hemp, providing hemp-processing services, and offering hemp-based products to consumers utilizing a direct-to-consumer marketing approach.

For full release:

In the Press:

March 13, 2020 - Coronavirus Outbreak Prompts Uptick in Cannabis Sales, Including Emergent Delivery Services

As COVID-19 continues to spread across the U.S., the implications are vast and complicated for business stakeholders and customers alike. International and domestic supply chains are feeling unprecedented economic pressure, and anyone monitoring the hourly news cycle is looking for clarity.

Kyle Kazan, CEO of Glass House Group in California, says that his background as a first responder is informing how he and his company are planning for uncertain times and an emergent public health crisis.

“What I would tell you is the first thing we do is we look at the data, strip out the emotion and say, ‘Okay, we have this wonderful supply chain, but it is worker-dependent. How do you keep people safe, so that they don’t contract a virus that nobody on the planet had immunity to three months ago?’” Kazan says. At the company’s recently expanded 505,000 square feet of greenhouse space, employees are maintaining distance between one another. Creative and accounting department employees, like those at many other companies this week, have begun working remotely.

The retail side of the business is a bit more complicated. Kazan says he’s watching what’s happening in the broader retail segment of commercial industries in Italy, for example, where the COVID-19 crisis is far more developed and horrific than where the U.S. stands—as of now. Businesses are shuttered as public officials promote social distancing policies and self-quarantine measures across the country. Public decisions like that could materialize very quickly in the U.S.

“Even if [businesses don’t close en masse], which I think they will, our plan is always for the extreme,” Kazan says. “If that happens, or if it doesn’t happen, then people are going to come in in a lot less numbers, but they’re still going to want to use cannabis. So, we’re moving very, very quickly to ramp up our delivery. We already have some delivery, and we are moving at lightning speed.”

For full release:

February 3, 2020 - Can You Travel with CBD Oil? What’s the Best Kind?

You can get CBD oil in your coffee, buy CBD oil bath bombs, CBD oil lotions, and even CBD oil dog treats. It’s a buzz-worthy topic in the health and wellness space, but many travelers are left confused about its legality, especially when they’re considering taking certain products on a plane or traveling internationally.

First off, let’s define what CBD oil actually is. According to Merriam-Webster, CBD is “a nonintoxicating cannabinoid found in cannabis and hemp,” and that CBD oils contain cannabidiol. The types of oils that we’re referring to are oils derived from the hemp plant (not marijuana) and contain only a minimal amount (less than 0.3 percent) of tetrahydrocannabinol, or THC, which is the intoxicating or psychoactive compound of the plant that makes users feel “high.” It’s common knowledge that this minimal amount of THC does not produce noticeably intoxicating side effects.

Thanks to some recent legal changes around CBD at the federal level, it’s becoming a bit more straightforward. Here’s what I learned about traveling with CBD oil after speaking with Sherri Tutkus, BSN-RN and founder/CEO of the GreenNurse Group, and Joshua Bauchner, a lawyer for the Canafarma Corporation.

Traveling with CBD Oil Domestically

The type of CBD oil that’s derived from hemp oil is what’s legal at a federal level (as of the 2018 Farm Bill) and therefore allowed to be taken across state borders, and, yes, on flights. Other CBD oils, like the type that’s derived from marijuana, are still illegal in some states—so it’s not recommended to take those types across state borders.

You can tell the difference between the two types of CBD oil by reading the product’s label and identifying the amount of THC in it. Only hemp-derived CBD oils (with THC levels below 0.3 percent) are legal to fly with or be taken across state borders in the U.S.  It’s also important to note that while CBD oil is legal at the federal level, certain state laws vary in terms of possession of any type of CBD oil.

Here’s the status of flying with CBD oil in the U.S. as of January 2020, according to the TSA’s website:

“Marijuana and certain cannabis-infused products, including some cannabidiol (CBD) oil, remain illegal under federal law except for products that contain no more than 0.3 percent THC on a dry weight basis or that are approved by FDA. (See the Agriculture Improvement Act of 2018, Pub. L. 115-334.) TSA officers are required to report any suspected violations of law to local, state or federal authorities.

“TSA’s screening procedures are focused on security and are designed to detect potential threats to aviation and passengers. Accordingly, TSA security officers do not search for marijuana or other illegal drugs, but if any illegal substance is discovered during security screening, TSA will refer the matter to a law enforcement officer.”


For full release:

January 28, 2020 - CBD startup CanaFarma goes public

Cannabis companies in New York have put their future on hold as they wait to see if the state will legalize adult use of the drug. CBD startups, meanwhile, are moving ahead at full speed. 

CanaFarma Corp., one of at least a half dozen New York companies that launched recently in the CBD field, is in the midst of going public on the Canadian Securities Exchange. It is projecting $45 million in revenue by the end of this year.

CBD, which is short for the non-intoxicating compound cannabidiol, is made from hemp, which is essentially the same plant that produces marijuana. In 2018, the U.S. Farm Bill legalized the cultivation and sale of hemp as long as it contained only trace amounts of tetrahydrocannabinol, or THC, the chemical that gets cannabis users high.

Founded last March, CanaFarma began selling its signature product, a hemp oil-infused chewing gum called Yooforic, in June. By October it was doing $750,000 a month in sales—entirely online—according to CEO David Lonsdale. He said the company was now planning its expansion into brick-and-mortar retail sales. It also produces a hemp oil tincture and is working on a skin cream. 

CBD’s proponents say it can provide relief for anxiety, insomnia, and ordinary aches and pains. A high-dosage version of the drug has been approved for the treatment of epileptic seizures in children. Medical experts, however, question what benefits CBD can have in small doses. 

There are also questions around the legality of CBD products. The Food and Drug Administration has said it considers the compound a drug and that it has not yet determined if it is safe to consume. New York City’s Department of Health, taking its lead from the FDA, has banned CBD from restaurants and cafes, although enforcement has been spotty

CBD companies have gotten around the regulations by not making medical claims for their products. CanaFarma has played it safe by describing its gum as a hemp-oil infusion.

The confusion over regulations has played havoc with some New York based CBD businesses, but it has not stopped their growth.

The regulatory environment “is a little bit blurry at the moment,” Lonsdale said. “But we’re bound and determined to be one of the major companies in this industry. We have the financing and we think we’ve got the strategy.”

A veteran of Dun & Bradstreet and other blue-chip firms, Lonsdale has run his own boutique investment company for the past decade. As part of going public, CanaFarma has merged with a British Columbia-based company, KYC Technology. 

Although CanaFarma appears to be the first New York based CBD company to go public in Canada, other companies in the sector have used the Canadian exchange because of more liberal laws north of the border governing cannabis-related products.

CanaFarma also has the means to produce CBD products literally from the ground up: It is a part-owner of Simple Solutions, which operates a 55-acre organic hemp farm in Duchess County. Lonsdale is looking into partnering with extraction and processing facilities in New Jersey.

“We expect the medical industry to catch up and document the benefits we’re seeing,” he said. “I think we’ve hardly scratched the surface of what CBD can do for us.”


For full release:

January 15, 2020 - New Cannabis Products: Hemp, CBD Soft Gels For Free, Mobile Verification System And A Concentrates Device

As the cannabis market expands, it’s hard to keep track of the many products that launch every week. Benzinga put together a short list of some of the most interesting new cannabis products launched recently.

Are you CBD curious but don’t want to fork over your hard earned money in case you don’t like it?

For the month of January Irwin Naturals is offering a free bottle of its 10 mg CBD soft gels. Just use promo code FREECBD10 when ordering the product: the $26.99 cost will change to free and you’ll just cover the $9.95 shipping and handling.

We asked Dr. Elijiah McCarthy, product formulator and wellness ambassador at Irwin Natuals, why the company is giving away its products.

“As a clinician, I’ve seen numerous patients receive health benefits from CBD only to realize that they cannot keep up with the high cost of daily CBD supplementation,” said Dr. McCarthy, product formulator and wellness ambassador for Irwin Naturals. “With the launch and distribution of our CBD product line, we are re-writing the narrative. Consumers no longer need to be concerned about the cost and quality of CBD. We got them covered.”

PearlCBD’s Tap Verification

PearlCBD launched a new technology that allows consumers to tap their mobile device to any product label and gain instant access to authenticity verification, batch-specific lab test results, educational content, and more. The company’s patent-pending technology has married NFC digital tags into PearlCBD’s product labels to enable consumers to gain transparency in real time and ensure they can trust that they are getting what the label says.


YOOFORIC launched a full spectrum botanical hemp oil line featuring four flavors: chocolate mint, peppermint, lemon citrus and passion fruit. All are vegan, non-GMO, and gluten free. 

“Through extensive research and development, we could not be more thrilled to launch our new YOOFORIC Premium Hemp Oil line. YOOFORIC Hemp Oil is vegan, non-gmo, gluten-free and now available in four great tasting flavors,” said Frank Barone, Chief Marketing Officer of Canafarma. “With this added product line, we look forward to continuing to provide consumers with quality products made from premium botanical hemp oil.”

For full release:

  • Sponsored Content Release, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

    Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For canafarma hemp products corp., financial and corporate news dissemination, has been compensated twenty thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: